Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2012 1
2013 6
2014 8
2015 18
2016 9
2017 13
2018 14
2019 15
2020 23
2021 25
2022 24
2023 19
2024 10

Text availability

Article attribute

Article type

Publication date

Search Results

162 results

Results by year

Filters applied: . Clear all
Page 1
What is the role of physical exercise in the era of cancer prehabilitation? A systematic review.
Del Bianco N, Borsati A, Toniolo L, Ciurnielli C, Belluomini L, Insolda J, Sposito M, Milella M, Schena F, Pilotto S, Avancini A. Del Bianco N, et al. Among authors: pilotto s. Crit Rev Oncol Hematol. 2024 Apr 18;198:104350. doi: 10.1016/j.critrevonc.2024.104350. Online ahead of print. Crit Rev Oncol Hematol. 2024. PMID: 38642726 Free article. Review.
The biomarkers ATLAS: An audit on 1100 non-small cell lung cancer from an Italian knowledge-based database.
Malapelle U, Passiglia F, Pepe F, Pisapia P, Lucia Reale M, Cortinovis D, Fraggetta F, Galetta D, Garbo E, Graziano P, Pagni F, Pasello G, Piovano P, Pilotto S, Tiseo M, Genova C, Righi L, Troncone G, Novello S. Malapelle U, et al. Among authors: pilotto s. Lung Cancer. 2024 Apr 5;191:107787. doi: 10.1016/j.lungcan.2024.107787. Online ahead of print. Lung Cancer. 2024. PMID: 38593479 Free article.
Osimertinib in Patients With Treatment-Naive EGFR-Mutant Non-small Cell Lung Cancer: Overall Survival, Post-progression Management and Budget Impact Analysis in Real-World.
Pasello G, Lorenzi M, Scattolin D, Del Conte A, Cecere F, Pavan A, Macerelli M, Polo V, Pilotto S, Santarpia M, Cumerlato E, Da Ros V, Targato G, Bortolami A, Bonanno L, Ferro A, Dal Maso A, Frega S, Guarneri V. Pasello G, et al. Among authors: pilotto s. Oncologist. 2024 Mar 23:oyae043. doi: 10.1093/oncolo/oyae043. Online ahead of print. Oncologist. 2024. PMID: 38520745 Free article.
Lung Cancer Screening: An Opportunity to Promote Physical Activity?
Avancini A, Belluomini L, Quist M, Pilotto S. Avancini A, et al. Among authors: pilotto s. JTO Clin Res Rep. 2024 Feb 20;5(3):100651. doi: 10.1016/j.jtocrr.2024.100651. eCollection 2024 Mar. JTO Clin Res Rep. 2024. PMID: 38496375 Free PMC article. No abstract available.
Cross-sectional survey evaluating the psychological impact of the COVID-19 vaccination campaign in patients with cancer: The VACCINATE study.
Tregnago D, Avancini A, Belluomini L, Trestini I, Sposito M, Insolda J, Bianchi F, Sava T, Gaiani C, Del Piccolo L, Guarnieri V, Verlato G, Tfaily A, Vesentini R, Zuliani S, Pilotto S, Milella M. Tregnago D, et al. Among authors: pilotto s. PLoS One. 2024 Jan 25;19(1):e0290792. doi: 10.1371/journal.pone.0290792. eCollection 2024. PLoS One. 2024. PMID: 38271378 Free PMC article.
Surface CD52, CD84, and PTGER2 mark mature PMN-MDSCs from cancer patients and G-CSF-treated donors.
Pettinella F, Mariotti B, Lattanzi C, Bruderek K, Donini M, Costa S, Marini O, Iannoto G, Gasperini S, Caveggion E, Castellucci M, Calzetti F, Bianchetto-Aguilera F, Gardiman E, Giani M, Dusi S, Cantini M, Vassanelli A, Pavone D, Milella M, Pilotto S, Biondani P, Höing B, Schleupner MC, Hussain T, Hadaschik B, Kaspar C, Visco C, Tecchio C, Koenderman L, Bazzoni F, Tamassia N, Brandau S, Cassatella MA, Scapini P. Pettinella F, et al. Among authors: pilotto s. Cell Rep Med. 2024 Feb 20;5(2):101380. doi: 10.1016/j.xcrm.2023.101380. Epub 2024 Jan 18. Cell Rep Med. 2024. PMID: 38242120 Free PMC article.
A Feasibility Study Investigating an Exercise Program in Metastatic Cancer Based on the Patient-Preferred Delivery Mode.
Avancini A, Borsati A, Baldo E, Ciurnelli C, Trestini I, Tregnago D, Belluomini L, Sposito M, Insolda J, Auriemma A, Fiorio E, Piacentini M, Schena F, Milella M, Pilotto S. Avancini A, et al. Among authors: pilotto s. Oncologist. 2024 Jan 11:oyae002. doi: 10.1093/oncolo/oyae002. Online ahead of print. Oncologist. 2024. PMID: 38206849 Free article.
Characterization of two transcriptomic subtypes of marker-null large cell carcinoma of the lung suggests different origin and potential new therapeutic perspectives.
Simbolo M, Centonze G, Gkountakos A, Monti V, Maisonneuve P, Golovco S, Sabella G, Del Gobbo A, Gobbo S, Ferrero S, Fabbri A, Pardo C, Garzone G, Prinzi N, Pusceddu S, Testi A, Rolli L, Mangogna A, Bercich L, Benvenuti MR, Bria E, Pilotto S, Berruti A, Pastorino U, Capella C, Infante M, Milella M, Scarpa A, Milione M. Simbolo M, et al. Among authors: pilotto s. Virchows Arch. 2024 Jan 3. doi: 10.1007/s00428-023-03721-4. Online ahead of print. Virchows Arch. 2024. PMID: 38168015
162 results